Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma-Reference-Cited by-同舟云学术

Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma

Published:2012-01 Issue:1 Volume:124 Page:21-25
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Einstein Mark H.,Frimer Marina,Kuo Dennis Y.-S.,Reimers Laura L.,Mehta Keyur,Mutyala Subhakar,Huang Gloria S.,Hou June Y.,Goldberg Gary L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference12 articles.

1. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers;Hamilton;Br J Cancer,2006

2. Clinical aspects of uterine papillary serous carcinoma;Hamilton;Curr Opin Obstet Gynecol,2008

3. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study;Randall;J Clin Oncol,2006

4. A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma;Geller;Gynecol Oncol,2010

5. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer;Lupe;Gynecol Oncol,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Isolated axillary lymph node metastasis in high-risk endometrial cancer;Frontiers in Oncology;2024-03-18

2. An Overview of Endometrial Cancer with Novel Therapeutic Strategies;Current Oncology;2023-08-27

3. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events;Computers in Biology and Medicine;2023-01

4. Uterine carcinosarcoma;Diagnosis and Treatment of Rare Gynecologic Cancers;2023

5. The “Sandwich” Schedule: A Well-Tolerated Adjuvant Treatment Both in Intermediate–High- and High-Risk Endometrial Cancer;Current Oncology;2022-11-26